T1	And 162 166	with
E1	And:T1 
T2	Condition 167 196	immune mediated enteropathies
E2	Condition:T2 
T3	And 197 200	who
E3	And:T3 
T4	Assertion 225 233	symptoms
E4	Assertion:T4 
A1	Assertion-Type-Value E4 possible
T5	Or 234 237	and
E5	Or:T5 
T6	Modifier 238 247	histology
E6	Modifier:T6 
T7	Eq-Comparison 248 250	on
E7	Eq-Comparison:T7 
T8	Procedure 251 274	oral budesonide therapy
E8	Procedure:T8 Name:T48
T9	Age 300 303	Age
E9	Age:T9 
T10	Eq-Comparison 304 313	<18 years
E10	Eq-Comparison:T10 Operator:T49 Value:T50 Temporal-Unit:T51
T11	Observation 328 348	stool gluten testing
E11	Observation:T11 Name:T53
T12	Condition 366 391	refractory celiac disease
E12	Condition:T12 Name:T54
T13	Condition 397 419	Small bowel malignancy
E13	Condition:T13 Name:T55
T14	Or 420 422	or
E14	Or:T14 
T15	Eq-Comparison 423 430	history
E15	Eq-Comparison:T15 Temporal-Period:T56
T16	Condition 434 456	small bowel malignancy
E16	Condition:T16 Name:T57
T17	Condition 462 487	Refractory celiac disease
E17	Condition:T17 Name:T58
T18	Eq-Comparison 488 494	type 2
E18	Eq-Comparison:T18 Value:T59
T19	Modifier 500 515	Post-transplant
E19	Modifier:T19 
T20	Condition 516 544	lymphoproliferative disorder
E20	Condition:T20 Name:T61
T21	Condition 556 567	enteropathy
E21	Condition:T21 Name:T62
T22	Negation 573 575	No
E22	Negation:T22 
T23	Eq-Comparison 576 581	prior
E23	Eq-Comparison:T23 Temporal-Period:T63
T24	Assertion 597 605	symptoms
E24	Assertion:T24 
A2	Assertion-Type-Value E24 possible
T25	And 606 609	and
E25	And:T25 
T26	Condition 610 619	histology
E26	Condition:T26 
T27	Procedure 625 643	budesonide therapy
E27	Procedure:T27 Name:T64
T28	Procedure 668 686	budesonide therapy
E28	Procedure:T28 Name:T65
T29	Temporal-Connection 687 695	prior to
E29	Temporal-Connection:T29 
A3	Temporal-Connection-Type-Value E29 before
T30	Study 700 705	trial
E30	Study:T30 
T31	Other 711 716	Other
E31	Other:T31 
T32	Modifier 728 736	systemic
E32	Modifier:T32 
T33	Drug 737 752	corticosteroids
E33	Drug:T33 Name:T66
T34	Other 758 763	Other
E34	Other:T34 
T35	Drug 764 792	immune mediating medications
E35	Drug:T35 Name:T67
T36	Negation 810 813	not
E36	Negation:T36 
T37	Drug 825 837	azathioprine
E37	Drug:T37 Name:T68
T38	Drug 844 860	6-mercaptopurine
E38	Drug:T38 Name:T69
T39	Drug 862 874	cyclosporine
E39	Drug:T39 Name:T70
T40	Drug 876 888	methotrexate
E40	Drug:T40 Name:T71
T41	Drug 890 920	anti-TNF monoclonal antibodies
E41	Drug:T41 Name:T72
T42	Drug 922 976	alpha-4 beta-7 integrin inhibiting monoclonal antibody
E42	Drug:T42 Name:T73
T43	Drug 978 1026	interleukin 12/23 inhibiting monoclonal antibody
E43	Drug:T43 Name:T74
T44	Drug 1028 1042	JAK inhibitors
E44	Drug:T44 Name:T75
T45	Location 112 136	Mayo Clinic in Rochester
A4	Location-Value T45 hospital
T46	Life-Stage-And-Gender 147 152	Adult
A5	Life-Stage-And-Gender-Type T46 adult
T47	Drug-Name 167 196	immune mediated enteropathies
T48	Procedure-Name 251 274	oral budesonide therapy
T49	Eq-Operator 304 305	<
A6	Eq-Operator-Value T49 LT
T50	Eq-Value 305 307	18
T51	Eq-Temporal-Unit 308 313	years
A7	Eq-Temporal-Unit-Value T51 year
T52	Polarity 319 327	Positive
A8	Polarity-Value T52 positive
T53	Observation-Name 328 348	stool gluten testing
A9	Observation-Type-Value T53 lab
T54	Condition-Name 366 391	refractory celiac disease
T55	Condition-Name 403 419	bowel malignancy
T56	Eq-Temporal-Period 423 430	history
A10	Eq-Temporal-Period-Value T56 past
T57	Condition-Name 440 456	bowel malignancy
T58	Condition-Name 462 487	Refractory celiac disease
T59	Eq-Value 493 494	2
T60	Procedure-Name 505 515	transplant
T61	Condition-Name 516 544	lymphoproliferative disorder
T62	Condition-Name 556 567	enteropathy
T63	Eq-Temporal-Period 576 581	prior
A11	Eq-Temporal-Period-Value T63 past
T64	Procedure-Name 625 643	budesonide therapy
T65	Procedure-Name 668 686	budesonide therapy
T66	Drug-Name 737 752	corticosteroids
T67	Drug-Name 764 792	immune mediating medications
T68	Drug-Name 825 837	azathioprine
T69	Drug-Name 844 860	6-mercaptopurine
T70	Drug-Name 862 874	cyclosporine
T71	Drug-Name 876 888	methotrexate
T72	Drug-Name 890 920	anti-TNF monoclonal antibodies
T73	Drug-Name 922 976	alpha-4 beta-7 integrin inhibiting monoclonal antibody
T74	Drug-Name 978 1026	interleukin 12/23 inhibiting monoclonal antibody
T75	Drug-Name 1028 1042	JAK inhibitors
